Search results for "Esquizofrènia"

showing 10 items of 20 documents

Using gene expression and systems biology to interrogate auditory hallucinations in schizophrenic patients

2015

Schizophrenia is a severe mental disorder affecting around 1% of the opulation. This disease presents a complex aetiology that has not been completely unveiled yet. Auditory hallucinations are a very significant and disruptive symptom of schizophrenia affecting between 60% and 80% of schizophrenic patients. In this paper we have used a network-based transcriptomic analysis aiming to identify differences in gene expression between schizophrenic patients with and without auditory hallucinations. Gene expression data from blood samples drained from 30 schizophrenia patients were generated using Affymetrix Human Gene 2.0 ST Genechips. Affymetrix Expression console was used for normalization and…

Genètica humanaEsquizofrèniaNeurociència computacional
researchProduct

FOXP2 expression and gray matter density in the male brains of patients with schizophrenia

2021

Common genetic variants ofFOXP2may contribute to schizophrenia vulnerability, but controversial results have been reported for this proposal. Here we evaluated the potential impact of the commonFOXP2rs2396753 polymorphism in schizophrenia. It was previously reported to be part of a risk haplotype for this disease and to have significant effects on gray matter concentration in the patients. We undertook the first examination into whether rs2396753 affects the brain expression ofFOXP2and a replication study of earlier neuroimaging findings of the influence of this genetic variant on brain structure.FOXP2expression levels were measured in postmortem prefrontal cortex samples of 84 male subject…

MaleCandidate geneSistema nerviós central MalaltiesFOXP2Cognitive NeurosciencePhysiologyBiology03 medical and health sciencesBehavioral NeuroscienceCellular and Molecular NeuroscienceMagnetic resonance imaging0302 clinical medicinemaleNeuroimagingexpressionGenetic variationmedicinemagnetic resonance imagingHumansRadiology Nuclear Medicine and imagingGray MatterPrefrontal cortexOriginal ResearchCerebral Cortexmedicine.diagnostic_testlanguage lateralizationsevere speechBrain morphometrysyndrome scale panssassociationNeuropsychologyBrainForkhead Transcription FactorsMagnetic resonance imagingFOXP2gray matterdisorder030227 psychiatryschizophreniaPsychiatry and Mental healthNeurologySchizophreniaEsquizofrèniagenetic-variationNeurology (clinical)polymorphisms030217 neurology & neurosurgeryBrain Imaging and Behavior
researchProduct

A comparison of the dental status and treatment needs of older adults with and without chronic mental illness in Sevilla, Spain

2012

Objectives: To study the dental status and treatment needs of institutionalized older adults with chronic mental illness compared to a non-psychiatric control sample. Study Design: The sample size was 100, in which 50 were psychogeriatric patients (study group; SG) classified according to DSM-IV, with a mean age of 69.6 ± 6.7 years, and 50 non-psychiatric patients (control group; CG), with a mean age of 68.3 ± 6.9 years. Clinical oral health examinations were conducted and caries were recorded clinically using the Decayed, Missing and Filled Teeth Index (DMFT). Results were analyzed statistically using the Student’s t-test or analysis of variance. Results: Caries prevalence was 58% and 62% …

MaleDecayed teethCross-sectional studyGerodontologyDentistryOral HealthOdontologíaGeriatric dentistryOral healthDental Care for Agedstomatognathic systemHumansMedicineGeneral DentistryAgedHealth Services Needs and DemandImplants dentalsbusiness.industryMental DisordersDMFT IndexDental implants:CIENCIAS MÉDICAS [UNESCO]Dental careCiencias de la saludstomatognathic diseasesCross-Sectional StudiesOtorhinolaryngologySpainSample size determinationChronic mental illnessMental illnessChronic DiseaseUNESCO::CIENCIAS MÉDICASDental Care for AgedSchizophreniaResearch-ArticleFemaleSurgeryEsquizofrèniaOdontologia geriàtricabusinessMalalties mentals
researchProduct

A Multicentre, Randomised, Controlled Trial of a Combined Clinical Treatment for First-Episode Psychosis

2021

Introduction: There is evidence that early intervention contributes to improving the prognosis and course of first-episode psychosis (FEP). However, further randomised treatment clinical trials are needed. Objectives: The aim of this study was to compare the efficacy of a combined clinical treatment involving Cognitive Behavioural Therapy (CBT) as an adjunctive to treatment-as-usual (TAU) (CBT+TAU) versus TAU alone for FEP. Patients and methods: In this multicentre, single-blind, randomised controlled trial, 177 participants were randomly allocated to either CBT+TAU or TAU. The primary outcome was post-treatment patient functioning. Results: The CBT+TAU group showed a greater improvement in…

Psychosismedicine.medical_specialtyanimal structuresPronòstic mèdicHealth Toxicology and MutagenesisPsicosiDiseasebehavioral disciplines and activitiesArticlelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawIntervention (counseling)Internal medicinemental disordersmedicineScopusHumansSingle-Blind Methodfirst-episode psychosisClinical treatmenttreatmentCognitive Behavioral Therapybusiness.industryStandard treatmentRPublic Health Environmental and Occupational HealthPsychosesCognitionmedicine.diseasePrognosisCombined Modality Therapy030227 psychiatryClinical trialTreatment Adherence and Complianceearly interventionTreatment OutcomePsychotic DisordersJCRSchizophreniaoutcomeMedicineEsquizofrèniabusinessrandomised controlled trial030217 neurology & neurosurgeryInternational Journal of Environmental Research and Public Health
researchProduct

Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of observational studies

2017

[Background] The objective of this study will be to synthesize the epidemiological evidence and evaluate the validity of the associations between central nervous system disorders and the risk of developing or dying from cancer.

Research designAnorexia NervosaBipolar DisorderMedicine (miscellaneous)lcsh:MedicineDisease0302 clinical medicineDown’s syndromeCentral Nervous System DiseasesNeoplasmsProtocolMedicine030212 general & internal medicineCàncerCancerDepressionIncidenceHuntington’sdiseaseAnorèxia nerviosaAutism spectrum disorders3. Good healthObservational Studies as TopicSystematic reviewResearch DesignMeta-analysisEsquizofrèniaAlzheimer’s diseaseHuntington’s diseasemedicine.medical_specialtyCentral nervous system disorderMultiple SclerosisBipolar disorderSistema nerviós central MalaltiesMEDLINEMultiple sclerosisParkinson’s Disease03 medical and health sciencesMeta-Analysis as TopicDown’s SyndromeHuntington’s DiseaseHumansAlzheimer’s DiseasePsychiatryIntensive care medicineEpilepsybusiness.industrylcsh:RAmyotrophic Lateral SclerosisCancerCentral Nervous System DisorderAnorexia nervosamedicine.diseaseAmyotrophic lateral sclerosisMeta-analysisReview Literature as TopicParkinson’s diseaseSystematic reviewSchizophreniaObservational Studies as TopicObservational studySystematic ReviewAutismebusiness030217 neurology & neurosurgerySystematic Reviews as TopicMeta-Analysis
researchProduct

1st International Experts' Meeting on Agitation: Conclusions Regarding the Current and Ideal Management Paradigm of Agitation

2018

Este artículo se encuentra disponible en la página web de la revista en la siguiente URL: https://www.frontiersin.org/articles/10.3389/fpsyt.2018.00054/full En este artículo científico participan los siguientes autores: Mario Amore, Guido Di Sciascio, Radu Ioan Florea, Marina Garriga, Gabriel Gonzalez, Kai G. Kahl, Per-Axel Karlsson, Jens Kuhn, Maria Margariti, Bruno Pacciardi, Konstantinos Papageorgiou, Maurizio Pompili, Fabrice Rivollier, Ángel Royuela, Gemma Safont, Joachim Scharfetter, Bo Skagen, Kazuhiro Tajima-Pozo y Pierre Vidailhet. Agitation is a heterogeneous concept without a uniformly accepted definition, however, it is generally considered as a state of cognitive and motor hype…

Schizophrenia - Treatment.Psychomotor agitationlcsh:RC435-571media_common.quotation_subjectPsychomotor disorders - Treatment.ReviewMotor HyperactivityPsicosis maníaco depresiva - Tratamiento.Esquizofrenia - Farmacoterapia.Psicomotricidad - Trastornos - Tratamiento.03 medical and health sciences0302 clinical medicinePromotion (rank)Bipolar disorder Clinical practice Management Psychomotor agitation Schizophrenia Psychiatry and Mental HealthNursinglcsh:Psychiatrymedicinebipolar disorder; clinical practice; management; psychomotor agitation; schizophreniaManic-depressive illness030212 general & internal medicineManic-Depressive illness - Treatment.media_commonPsychiatrybipolar disorderProtocol (science)Psicosis maníaco depresiva - Farmacoterapia.Trastorn bipolarHealth professionalsCognitionManic-Depressive illnes - Chemotherapy.clinical practice030227 psychiatryschizophreniaClinical PracticeSchizophrenia - Chemotherapy.Psychiatry and Mental healthpsychomotor agitationSchizophreniaEsquizofrèniaEsquizofrenia - Tratamiento.medicine.symptomEmotional arousalPsychologymanagement
researchProduct

Genetic and psychosocial stressors have independent effects on the level of subclinical psychosis: findings from the multinational EU-GEI study.

2022

the Spanish Ministry of Science and Innovation. Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012, PI19/024), co-financed by ERDF Funds from the European Commission, ‘A way of making Europe’, CIBERSAM. Madrid Regional Government (B2017/BMD-3740 AGES-CM-2), European Union Structural Funds. European Union Seventh Framework Program under grant agreements FP7-4-HEALTH-2009-2.2.1-2-241909 (Project EU-GEI) and FP7-HEALTH-2013-2.2.1-2-603196 (Project PSYSCAN); and European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement No 115916, Project PRISM, and grant agreement No 777394, Project AIMS-2-TRIALS) (...)

Schizophrenia/geneticsEnvironmental effects on human beingsRisk factors in diseasesEpidemiologyPsicosipsychosiPathological psychologyGenes × environment interactionRisk FactorsSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.psychosocial stressorsHumanspsychosisPsychotic Disorders/geneticsSettore MED/25 - PsichiatriaInfluència del medi ambient en l'homeGenètica de la conductaFactors de risc en les malaltiesGenes × environment interactionsPublic Health Environmental and Occupational HealthPsychosespolygenic risk score for schizophreniaPsicopatologiaPsychiatry and Mental healthPsychotic DisordersBehavior geneticsSchizophreniaEsquizofrèniaGene-Environment Interaction
researchProduct

Social cogniction and comunication skills in Asperger síndrome Young adults

2013

The aim of this study is to compare patients with Asperger syndrome (AS) and control participants on social cognition tasks and communication skills. Twenty young adults were assessed in three social cognition domains; recognition of basic emotions, recognition of complex emotions and Theory of Mind (ToM). In addition participants completed a self-report questionnaire as a measure of social communication skills. The results indicate that adults with AS perform below neurotypical control participants in emotion processing, ToM and communication skills. There were no significant correlations between the variables of social cognition and communication skills in the group of AS. Taken together,…

educationEsquizofrèniabehavioral disciplines and activities
researchProduct

Comparing neurocognitive impairment in schizophrenia and bipolar I disorder using the Screen for Cognitive Impairment in Psychiatry Scale

2014

AbstractThe purpose of this study was to compare the psychometric properties of the Screen for Cognitive Impairment in Psychiatry (SCIP) when applied to patients diagnosed with schizophrenia (n=126) or bipolar I disorder (n=76), and also to compare the cognitive impairment in both samples of patients and a control group (n=83) using the SCIP and a complete neuropsychological battery. The SCIP is a scale intended to quickly and easily assess cognitive impairment in patients with severe psychiatric disorders. The results showed firstly that, in terms of internal consistency, temporal stability, dimensional structure, and criterion-referenced validity, the SCIP provides reliable and valid scor…

medicine.medical_specialtyBipolar I disorderCognition disordersBipolar disorderlcsh:BF1-990EsquizofreniaDeterioro cognitivoTrastorns de la cognicióInstrumental studymedicineManic-depressive illnessIn patientBipolar disorderCognitive impairmentPsychiatryTrastorn bipolarTrastorno bipolarEstudio instrumentalNeuropsychological batterymedicine.diseaseScreen for Cognitive Impairment in PsychiatryClinical PsychologyCognitive impairmentlcsh:PsychologySchizophreniaSchizophreniaEsquizofrèniaVerbal memoryPsychologyNeurocognitiveInternational Journal of Clinical and Health Psychology
researchProduct

Rol de les xarxes perineuronals en la plasticitat d'interneurones de l'escorça cerebral adulta

2018

L’esquizofrènia és un trastorn psiquiàtric complex que afecta a aproximadament el 1% de la població mundial. Tot i que els mecanismes etiopatològics exactes romanen sense esclarir, un recent cos d’evidències apunta a la possible implicació de les xarxes perineuronals, uns agregats especialitzats de la matriu extracel·lular presents en el neocòrtex de mamífers. La formació de les xarxes perineuronals durant el desenvolupament postnatal, el seu possible paper en el control de la plasticitat sinàptica i la seva co-localització amb diferents poblacions neuronals GABAèrgiques que expressen parvalbúmina, suggereixen que l’alteració d’aquestes estructures podria trencar el balanç d’excitació/inhib…

plasticitat sinàptica:CIENCIAS DE LA VIDA::Biología celular [UNESCO]biologia cel·lularUNESCO::CIENCIAS DE LA VIDA::Otras especialidades de la biologíaesquizofrèniaUNESCO::CIENCIAS DE LA VIDA::Biología celular:CIENCIAS DE LA VIDA::Otras especialidades de la biología [UNESCO]neurobiologia
researchProduct